GOAL试验:门诊综合老年评估对衰弱老年CKD患者目标达成的影响
GOAL是一项开放标签、整群随机对照试验,在澳大利亚15个肾脏门诊中心纳入240例65岁以上(原住民55岁以上)、eGFR≤59 mL/min/1.73 m²且衰弱指数>0.25的CKD患者,比较单次门诊综合老年评估(CGA)加常规照护与常规照护 alone。主要终点为3个月时目标达成量表(GAS)评分,结果显示两组无显著差异(45.2 vs 43.7;均差1.54,95%CI -3.13至6.20),次要结局亦无显著差异,不支持常规实施单次门诊CGA。
要点
- 单次门诊CGA未改善衰弱老年CKD患者3个月目标达成(GAS均差1.54,95%CI -3.13至6.20)。
- 次要结局(生活质量、衰弱、死亡、住院、养老院入住)均无显著差异。
- 干预组总住院时间减少2.5天,但未达统计学显著。
核心结论
- 门诊单次CGA未改善衰弱老年CKD患者的目标达成或临床结局,不支持在该场景常规实施单次门诊CGA。
研究设计与样本
- 开放标签、整群随机对照试验,澳大利亚15个肾脏门诊中心1:1随机分配至单次门诊CGA+常规照护或常规照护 alone。
- 筛查771例,纳入240例(平均年龄76.9岁;衰弱指数中位数0.39;男性56%),179例(74.6%)完成随访。
- 纳入标准:年龄≥65岁(原住民≥55岁),中重度CKD(eGFR≤59 mL/min/1.73 m²),衰弱指数>0.25。
- 主要终点为3个月时目标达成量表(GAS)评分,采用混合效应线性回归分析,意向性治疗分析。
主要发现
- 3个月时GAS均分干预组45.2 vs 对照组43.7,均差1.54(95%CI -3.13至6.20),无显著差异。
- 次要结局(生活质量、衰弱状态、死亡、住院、养老院入住)均无显著差异。
- 干预组总住院时间减少2.5天,但未达统计学显著。
关键数值与推荐
- GAS均分≥50提示目标达成;本试验两组均未达到该阈值。
- GAS均差1.54(95%CI -3.13至6.20),无统计学 significance。
临床怎么用
- 不建议在衰弱老年CKD门诊患者中常规开展单次综合老年评估。
- 需探索替代的、整合式的以人为中心照护模式。
局限性
- 随访完成率74.6%,存在失访偏倚可能。
- 单次CGA可能不足以产生持续效果,未评估多次或整合式CGA模式。
- 整群随机设计可能受中心间差异影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Frail older adults with chronic kidney disease (CKD) often experience complex care needs that may benefit from a comprehensive geriatric assessment (CGA). Our GOAL trial evaluated whether an outpatient CGA could improve patient-centered goal attainment in this population. METHODS: GOAL was an open-label, cluster-randomized controlled trial conducted across 15 Australian kidney outpatient centers from March 2021 to June 2023, with a 12-month follow-up. Centers randomized 1:1, delivered a single outpatient CGA plus usual care or usual care alone. Participants were aged 65 years and older (55 years and older for First Nations peoples) with moderate to severe CKD (eGFR 59 mL/min per 1.73 m2 and under) and frail (Frailty Index over 0.25). Of 771 screened, 240 were enrolled (mean age 76.9 years; median Frailty Index 0.39; 56% male), and 179 (74.6%) completed follow-up. In intervention centers, geriatricians performed a one-off CGA and provided individualized management plans. The primary outcome was goal attainment at three months, assessed using Goal Attainment Scaling (GAS), where a mean score of 50 or more indicates goal achievement. Mixed-effects linear regression was used for analysis. Secondary outcomes included quality of life, frailty status, mortality, hospitalizations, and residential aged care admission. All analyses were intention-to-treat at both cluster and participant levels. RESULTS: At three months, mean GAS scores were not significantly different between the intervention and control groups (45.2 vs 43.7; mean difference 1.54, 95% confidence interval: 3.13 to 6.20). No significant differences were found across secondary outcomes. A non-statistically significant reduction of 2.5 days in total hospital stay was observed in the intervention group. CONCLUSIONS: Outpatient CGA did not improve goal attainment or clinical outcomes in frail older adults with CKD. These findings do not support routine implementation of single-episode outpatient CGA in this setting and suggest a need for alternative, integrated models of person-centered care. TRIAL REGISTRATION: Registered at ClinicalTrials.gov with study number NCT04538157.
引用
- Logan B, Viecelli AK, Johnson DW, et al. A cluster randomized controlled trial (GOAL trial) evaluated a comprehensive geriatric assessment for frail older people with chronic kidney disease. Kidney Int. 2026. PMID: 42315016. doi:10.1016/j.kint.2026.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。